How Proper IV Access Selection Reduces Liability

An INS-Aligned Risk Management Approach for Healthcare Facilities

IV therapy is one of the most common clinical interventions in healthcare—but it is also one of the most litigated when complications occur. Infiltration injuries, extravasation, CLABSI events, thrombosis, and therapy delays can expose facilities to regulatory scrutiny and legal risk.

According to the Infusion Nurses Society (INS) Standards of Practice, vascular access device (VAD) selection must be based on a structured assessment of therapy type, duration, osmolarity, pH, patient condition, and vessel health—not convenience.

When the right device is selected from the start, facilities reduce:

• Complications

• Hospital transfers

• Survey deficiencies

• Documentation gaps

• Legal exposure

At Optimus Vascular, we help facilities apply INS-aligned decision frameworks that protect both patients and organizations.

Why IV Access Selection Is a Liability Issue

Improper vascular access selection commonly leads to:

1. Extravasation Injuries

Vesicant or cytotoxic medications administered through inappropriate peripheral access increase the risk of tissue necrosis and surgical intervention.

INS guidance clearly states that vesicants and high-risk irritants should be administered through central venous access when appropriate.

2. CLABSI and Infection Risk

Placing a central line when peripheral or midline access would have sufficed exposes the patient—and facility—to avoidable central line risks.

Overuse of central lines can trigger:

• Infection risk

• Regulatory flags

• Quality metric impact

INS emphasizes selecting the least invasive device that safely meets therapy needs.

3. Therapy Delays and Reinsertions

Repeated failed peripheral IV attempts:

• Increase patient harm

• Delay antibiotics or critical medications

• Create documentation exposure

INS recommends early escalation to alternative access when peripheral attempts are unsuccessful or inappropriate.

4. Regulatory and Survey Exposure

Surveyors increasingly evaluate:

• Documentation of device selection rationale

• Evidence of therapy-based decision making

• Monitoring practices

Facilities must demonstrate that vascular access decisions follow accepted standards—not habit.

INS-Aligned Device Selection Principles That Reduce Risk

The Infusion Nurses Society promotes a structured approach that considers:

• Medication characteristics (vesicant, irritant, osmolarity, pH)

• Expected duration of therapy

• Patient diagnosis and comorbidities

• Vein condition and preservation goals

• History of difficult access

• Frequency of blood sampling

Key Risk-Reduction Concept:

Use the device that safely supports the therapy—no more, no less.

Examples:

Clinical Scenario	Risk-Reducing Access Decision
Short-term isotonic antibiotics	Peripheral IV or Midline
Vesicant chemotherapy	Central line required
Prolonged IV therapy (>2–4 weeks)	PICC or appropriate central device
Repeated peripheral failures	Escalate early to advanced access

This structured approach protects both patient outcomes and facility defensibility.

Documentation: The Hidden Liability Shield

One of the most overlooked risk-reduction tools is clear documentation of the access decision process.

INS supports documentation that reflects:

• Clinical reasoning

• Therapy assessment

• Ongoing evaluation

• Patient education and informed consent

When documentation reflects evidence-based decision making, liability exposure decreases significantly.

How Optimus Vascular Supports Facilities

• Evidence-Based Line Selection

We collaborate with providers and nursing leadership to determine the safest and most appropriate device for each therapy.

• Ultrasound-Guided Expertise

Accurate placement reduces:

1. Multiple attempts

2. Vessel trauma

3. Delays in care

• Education and Consultation

We help teams understand:

1. Vesicant vs irritant classifications

2. Osmolarity considerations

3. Duration-based device decisions

4. When to escalate access

• Reduced Avoidable Hospital Transfers

Proper line selection decreases:

1. IV complications

2. Failed therapy

3. Emergency transfers related to access issues

The Financial Impact of Proper IV Access Selection

When vascular access is chosen correctly:

• Fewer adverse events

• Reduced readmissions

• Lower legal risk

• Better quality metrics

• Improved patient satisfaction

Proper access selection is not just clinical best practice—it is a strategic risk management decision.

A Proactive Approach to IV Safety

Facilities that treat vascular access as a specialized clinical decision—not just a task—experience measurable improvements in safety and compliance.

At Optimus Vascular, we support healthcare teams with:

• Rapid response access services

• INS-aligned decision support

• Device expertise

• Ongoing collaboration

Safer line selection protects patients.

Structured decision-making protects facilities.